Descrição
Supplementary quantification of lipid droplets and cholesterol levels in prostate cancer cells under various melatonin treatment conditions.
Figure 33
ChartSource Paper
Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.Cite This Figure
![Figure 33: Supplementary quantification of lipid droplets and cholesterol levels in prostate cancer cells under various melatonin treatment conditions.]() > Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)
<figure> <img src="" alt="Supplementary quantification of lipid droplets and cholesterol levels in prostate cancer cells under various melatonin treatment conditions." /> <figcaption>Figure 33. Supplementary quantification of lipid droplets and cholesterol levels in prostate cancer cells under various melatonin treatment conditions.<br> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption> </figure>